Efficacy and safety of Compound E'jiao Jiang for treating leukopenia based: a systematic review and Meta-analysis.

ABSTRACT:

Objective

To systematically assess the safety and effectiveness of Compound E'jiao Jiang (, CEJ) for treating leukopenia.

Methods

Four English and four Chinese databases were searched for randomized controlled trials (RCTs) on CEJ for treating leukopenia up to July 1, 2024. Two researchers independently screened the studies and extracted necessary data. Methodological quality and risk of bias were assessed using the Cochrane risk-of-bias tool. Articles eligible for Meta-analysis were analyzed using RevMan.

Results

A total of 28 RCTs involving 2041 participants were included, with 1034 in the experimental group and 1007 in the control group. The Meta-analysis showed a significant effect of CEJ in treating leukopenia caused by tumor and immune diseases (three RCTs) [ris

SUBMITTER: Zhenkai LU 

PROVIDER: S-EPMC12453994 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature